Protective effects of PACAP in excitotoxic striatal lesion

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The present article investigated the effects of pituitary adenylate cyclase-activating polypeptide (PACAP) treatment in a quinolinic acid (QA)-induced unilateral lesion of the striatum, a model of Huntington's disease (HD). PACAP was given locally, preceding the lesion. Behavioral analysis was performed after 1, 10, and 30 days, when motor activity and asymmetrical signs were evaluated. Three weeks after the treatment, a catalepsy test was performed by haloperidol administration, and finally histological assessment of the striatum was done. Our results show that PACAP treatment attenuated the behavioral deficits and reduced the number of lesioned neurons in the striatum.

Original languageEnglish
Pages (from-to)570-574
Number of pages5
JournalAnnals of the New York Academy of Sciences
Volume1070
DOIs
Publication statusPublished - Jul 2006

Keywords

  • Huntington's disease
  • Neuroprotection
  • PACAP
  • Quinolinic acid
  • Striatum

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Fingerprint Dive into the research topics of 'Protective effects of PACAP in excitotoxic striatal lesion'. Together they form a unique fingerprint.

  • Cite this